Related Experiment Video
Updated: Jun 14, 2025

05:33
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
1.3K
Distinct Types of Regulated Cell Death in Melanoma
Qi Wu1,2, Shuang Liang2, Guo-Jun Shi1
1Department of Pharmacology, School of Pharmacy, Nantong University, Nantong 226001, China.
Cells
|June 11, 2025
Summary
Regulated cell death (RCD) pathways like apoptosis, pyroptosis, and ferroptosis are crucial in melanoma progression and treatment resistance. Targeting these RCD mechanisms offers promising therapeutic strategies for suppressing melanoma.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Resistance to cell death is a key characteristic of cancer, especially in melanoma.
- Abnormalities in cell death regulation are linked to melanoma's malignant progression and resistance to therapy.
Purpose of the Study:
- To systematically review the roles and mechanisms of various regulated cell death (RCD) types in melanoma.
- To explore the potential of targeting RCD pathways for melanoma treatment.
Main Methods:
- Systematic review of literature on RCD in melanoma.
- Analysis of distinct RCD pathways including apoptosis, autophagy, pyroptosis, immunogenic cell death, necroptosis, and ferroptosis.
- Examination of therapeutic strategies targeting RCD.
Main Results:
- Multiple RCD types (apoptosis, autophagy, pyroptosis, immunogenic cell death, necroptosis, ferroptosis) are implicated in melanoma.
- Autophagy can promote melanoma survival but excessive activation leads to cell death.
- Necroptosis and pyroptosis can enhance anti-melanoma immune responses and immunotherapy efficacy.
- Ferroptosis targets specific axes (SLC7A11/GPX4) to overcome melanoma resistance.
Conclusions:
- Regulated cell death pathways play multifaceted roles in melanoma development and treatment.
- Targeting RCD pathways, including ferroptosis and necroptosis, shows significant therapeutic potential for melanoma.
- Developing agents targeting RCD pathways is a promising strategy for melanoma suppression.
Related Concept Videos
Overview of Cell Death
7.1K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.1K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Apoptosis
11.3K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.3K

